Results of an Interim Analysis of a Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of ZGN-1061 in Patients with Obesity and Type 2 Diabetes

被引：0
|
作者：
Kim, Terri
Zhuang, Dongliang
Hughes, Thomas E.
Kim, Dennis D.
Taylor, Kristin
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-105-LB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trial
    Pariser, David M.
    Bagel, Jerry
    Lebwohl, Mark
    Yosipovitch, Gil
    Chien, Elaine
    Spellman, Mary C.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (06) : 1314 - 1320
  • [12] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
    Goodman, A. D.
    Rossman, H.
    Bar-Or, A.
    Miller, A.
    Miller, D. H.
    Schmierer, K.
    Lublin, F.
    Khan, O.
    Bormann, N. M.
    Yang, M.
    Panzara, M. A.
    Sandrock, A. W.
    NEUROLOGY, 2009, 72 (09) : 806 - 812
  • [13] Efficacy and Safety of HS-20094 in Patients with Type 2 Diabetes-A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
    Liu, Lin
    Shi, Xiaoxia
    He, Fei
    Cheng, Zhifeng
    Song, Weihong
    Wang, Zhongjing
    Cui, Yimin
    Zhang, Junqing
    DIABETES, 2024, 73
  • [14] Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double-blind, placebo-controlled, phase 3 trial
    Lu, Juming
    Fu, Liujun
    Li, Yan
    Geng, Jianlin
    Qin, Li
    Li, Ping
    Zheng, Hailong
    Sun, Zilin
    Li, Yanbing
    Zhang, Lihui
    Sun, Yadong
    Chen, Daoxiong
    Qin, Guijun
    Lu, Weiping
    Guo, Yushan
    Zhang, Yuwei
    Liu, Haiyan
    Zhang, Tao
    Zou, Jianjun
    DIABETES OBESITY & METABOLISM, 2021, 23 (05): : 1111 - 1120
  • [15] PAIS 2 (Paracetamol [Acetaminophen] in Stroke 2): Results of a Randomized, Double-Blind Placebo-Controlled Clinical Trial
    de Ridder, Inger R.
    den Hertog, Heleen M.
    van Gemert, H. Maarten A.
    Schreuder, A. H. C. M. L.
    Ruitenberg, Annemieke
    Maasland, E.
    Saxena, Ritu
    van Tuijl, Jordie H.
    Jansen, Ben P. W.
    Van den Berg-Vos, Renske M.
    Vermeij, Frederique
    Koudstaal, Peter J.
    Kappelle, L. Jaap
    Algra, Ale
    van der Worp, H. Bart
    Dippel, Diederik W. J.
    STROKE, 2017, 48 (04) : 977 - 982
  • [16] Pantoprazole Improves Glycemic Control in Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
    Singh, Pawan Kumar
    Hota, Debasish
    Dutta, Pinaki
    Sachdeva, Naresh
    Chakrabarti, Amitava
    Srinivasan, Anand
    Singh, Inderjeet
    Bhansali, Anil
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (11): : E2105 - E2108
  • [17] SERLOPITANT FOR TREATMENT OF CHRONIC PRURITUS: RESULTS OF A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 CLINICAL TRIAL
    Yosipovitch, Gil
    Stander, Sonja
    Kerby, Matthew B.
    Larrick, James W.
    Perlman, Andrew J.
    Schnipper, Edward F.
    Zhang, Xiaoming
    Tang, Jean Y.
    Luger, Thomas A.
    Steinhoff, Martin
    ACTA DERMATO-VENEREOLOGICA, 2017, 97 (08) : 1015 - 1015
  • [18] Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial
    Yang, Wenying
    Zhu, Dalong
    Gan, Shenglian
    Dong, Xiaolin
    Su, Junping
    Li, Wenhui
    Jiang, Hongwei
    Zhao, Wenjuan
    Yao, Minxiu
    Song, Weihong
    Lu, Yibing
    Zhang, Xiuzhen
    Li, Huifang
    Wang, Guixia
    Qiu, Wei
    Yuan, Guoyue
    Ma, Jianhua
    Li, Wei
    Li, Ziling
    Wang, Xiaoyue
    Zeng, Jiao'e
    Yang, Zhou
    Liu, Jingdong
    Liang, Yongqian
    Lu, Song
    Zhang, Huili
    Liu, Hui
    Liu, Ping
    Fan, Kuanlu
    Jiang, Xiaozhen
    Li, Yufeng
    Su, Qing
    Ning, Tao
    Tan, Huiwen
    An, Zhenmei
    Jiang, Zhaoshun
    Liu, Lijun
    Zhou, Zunhai
    Zhang, Qiu
    Li, Xuefeng
    Shan, Zhongyan
    Xue, Yaoming
    Mao, Hong
    Shi, Lixin
    Ye, Shandong
    Zhang, Xiaomei
    Sun, Jiao
    Li, Ping
    Yang, Tao
    Li, Feng
    NATURE MEDICINE, 2022, 28 (05) : 974 - +
  • [19] Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial
    Dalong Zhu
    Xiaoying Li
    Jianhua Ma
    Jiao’e Zeng
    Shenglian Gan
    Xiaolin Dong
    Jing Yang
    Xiaohong Lin
    Hanqing Cai
    Weihong Song
    Xuefeng Li
    Keqin Zhang
    Qiu Zhang
    Yibing Lu
    Ruifang Bu
    Huige Shao
    Guixia Wang
    Guoyue Yuan
    Xingwu Ran
    Lin Liao
    Wenjuan Zhao
    Ping Li
    Li Sun
    Lixin Shi
    Zhaoshun Jiang
    Yaoming Xue
    Hongwei Jiang
    Quanmin Li
    Zongbao Li
    Maoxiong Fu
    Zerong Liang
    Lian Guo
    Ming Liu
    Chun Xu
    Wenhui Li
    Xuefeng Yu
    Guijun Qin
    Zhou Yang
    Benli Su
    Longyi Zeng
    Houfa Geng
    Yongquan Shi
    Yu Zhao
    Yi Zhang
    Wenying Yang
    Li Chen
    Nature Medicine, 2022, 28 : 965 - 973
  • [20] Dorzagliatin add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial
    Wenying Yang
    Dalong Zhu
    Shenglian Gan
    Xiaolin Dong
    Junping Su
    Wenhui Li
    Hongwei Jiang
    Wenjuan Zhao
    Minxiu Yao
    Weihong Song
    Yibing Lu
    Xiuzhen Zhang
    Huifang Li
    Guixia Wang
    Wei Qiu
    Guoyue Yuan
    Jianhua Ma
    Wei Li
    Ziling Li
    Xiaoyue Wang
    Jiao’e Zeng
    Zhou Yang
    Jingdong Liu
    Yongqian Liang
    Song Lu
    Huili Zhang
    Hui Liu
    Ping Liu
    Kuanlu Fan
    Xiaozhen Jiang
    Yufeng Li
    Qing Su
    Tao Ning
    Huiwen Tan
    Zhenmei An
    Zhaoshun Jiang
    Lijun Liu
    Zunhai Zhou
    Qiu Zhang
    Xuefeng Li
    Zhongyan Shan
    Yaoming Xue
    Hong Mao
    Lixin Shi
    Shandong Ye
    Xiaomei Zhang
    Jiao Sun
    Ping Li
    Tao Yang
    Feng Li
    Nature Medicine, 2022, 28 : 974 - 981
12345